Clinical Trial Update: Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd [Phase 3]

View source ↗

Summary

A Phase 3 bronchoprovocation trial is planned to demonstrate pharmacodynamic bioequivalence of Macleods' Albuterol Sulfate HFA inhalation aerosol in individuals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol Sulfate HFA Inhalation Aerosol (albuterol sulfate)

Snippet

Sponsor: Macleods Pharmaceuticals Ltd | Conditions: Mild Asthma | Phase 3 | Status: NOT_YET_RECRUITING